Correlation Between Pfizer and Bravada Gold

Can any of the company-specific risk be diversified away by investing in both Pfizer and Bravada Gold at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Bravada Gold into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Bravada Gold, you can compare the effects of market volatilities on Pfizer and Bravada Gold and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Bravada Gold. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Bravada Gold.

Diversification Opportunities for Pfizer and Bravada Gold

-0.21

Correlation Coefficient

Pfizer  Bravada Gold

Very good diversification

The 3 months correlation between Pfizer and Bravada is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Bravada Gold in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bravada Gold and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Bravada Gold. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bravada Gold has no effect on the direction of Pfizer i.e., Pfizer and Bravada Gold go up and down completely randomly.

Pair Corralation between Pfizer and Bravada Gold

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Bravada Gold. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 9.49 times less risky than Bravada Gold. The stock trades about -0.05 of its potential returns per unit of risk. The Bravada Gold is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1.02  in Bravada Gold on December 29, 2024 and sell it today you would earn a total of  1.38  from holding Bravada Gold or generate 135.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.83%
Values	Daily Returns

Pfizer Inc  vs.  Bravada Gold

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Bravada Gold

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bravada Gold are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Bravada Gold reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Bravada Gold

The main advantage of trading using opposite Pfizer and Bravada Gold positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Bravada Gold can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bravada Gold will offset losses from the drop in Bravada Gold's long position.

The idea behind Pfizer Inc and Bravada Gold pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..